The company celebrated 65-years of providing industrial vacuum cleaning systems to the market.
Vac-U-Max, an industrial vacuum cleaning systems provider in Bellville, NJ, announced 2019 was a banner year for company milestones.
According to a Nov. 12, 2019 company press release, the company celebrated 65-years of supplying the market with the world’s first industrial vacuum cleaners that operated on compressed-air for high volume recovery of combustible and flammable materials. They also celebrated the 50th work-year anniversary of Steve Pendleton, who announced his retirement as president of the company and the appointment of Doan Pendleton, his son, to the position.
“Fifty years ago, I filled an open sales position offered to me by my father Frank, selling compressed-air powered vacuum cleaners from the trunk of my car,” said Steve Pendleton, in the press release. “The past 50 years have been the best memories of my life, with a fantastic team of dedicated and loyal employees along the way.”
“I am both humbled and honored for this opportunity to serve as president,” added Doan Pendleton, in the press release. “My father was the first to see the true potential of Vac-U-Max and is responsible for growing Vac-U-Max to where it is today. I cannot thank him enough for his vision, leadership, perseverance, and contributions. He is the true pioneer and visionary and will continue as [c]hairman of the [b]oard.”
The company also introduced its new Model 1050, a continuous-duty industrial vacuum cleaner designed for high volume recovery of high-density and abrasive materials including steel shot, grit, cement, foundry sand, and other similar materials. The new vacuum is equipped to vacuum up to 10,000 lbs (4500 kg) pr/hr from distances up to 30 feet (9 m) away.
Source: Vac-U-Max
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
2 Commerce Drive
Cranbury, NJ 08512